Focused Wealth Management, Inc - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 6 filers reported holding REGENERON PHARMACEUTICALS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q3 2020$211,000
+603.3%
4,000
-37.5%
0.05%
+411.1%
Q1 2020$30,0006,4000.01%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q4 2020
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 72,600$42,916,0000.05%
JANE STREET GROUP, LLC 74,600$44,098,0000.02%
GROUP ONE TRADING, L.P. 11,800$6,975,0000.01%
HRT FINANCIAL LP 700$413,0000.01%
Allianz Asset Management GmbH 1,500$887,0000.00%
JPMORGAN CHASE & CO 3,100$1,833,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders